454 related articles for article (PubMed ID: 20643584)
1. Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.
Gao X; Jiao Y; Wang L; Liu X; Sun W; Cui B; Chen Z; Zhao Y
Clin Immunol; 2010 Oct; 137(1):139-46. PubMed ID: 20643584
[TBL] [Abstract][Full Text] [Related]
2. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
[TBL] [Abstract][Full Text] [Related]
3. HLA-C and KIR genes in hepatitis C virus infection.
Montes-Cano MA; Caro-Oleas JL; Romero-Gómez M; Diago M; Andrade R; Carmona I; Aguilar Reina J; Núñez-Roldán A; González-Escribano MF
Hum Immunol; 2005 Nov; 66(11):1106-9. PubMed ID: 16571411
[TBL] [Abstract][Full Text] [Related]
4. Evidence for natural killer cell-mediated protection from metastasis formation in uveal melanoma patients.
Maat W; van der Slik AR; Verhoeven DH; Alizadeh BZ; Ly LV; Verduijn W; Luyten GP; Mulder A; van Hall T; Koning F; Jager MJ; van Bergen J
Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2888-95. PubMed ID: 19234348
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphism of NK receptors and their ligands in melanoma patients: prevalence of inhibitory over activating signals.
Naumova E; Mihaylova A; Stoitchkov K; Ivanova M; Quin L; Toneva M
Cancer Immunol Immunother; 2005 Feb; 54(2):172-8. PubMed ID: 15248031
[TBL] [Abstract][Full Text] [Related]
6. Polymorphic HLA-C Receptors Balance the Functional Characteristics of KIR Haplotypes.
Hilton HG; Guethlein LA; Goyos A; Nemat-Gorgani N; Bushnell DA; Norman PJ; Parham P
J Immunol; 2015 Oct; 195(7):3160-70. PubMed ID: 26311903
[TBL] [Abstract][Full Text] [Related]
7. Association of killer cell immunoglobulin-like receptors and human leukocyte antigen-C genotypes in South Brazilian with type 1 diabetes.
Jobim M; Chagastelles P; Salim PH; Portela P; Wilson TJ; Curti AG; Jobim MR; João DA; Nardi NB; Tschiedel B; Jobim LF; Roesler R; Schwartsmann G
Hum Immunol; 2010 Aug; 71(8):799-803. PubMed ID: 20580654
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory killer cell immunoglobulin-like receptor KIR3DL1 in combination with HLA-B Bw4iso protect against ankylosing spondylitis.
Mousavi T; Poormoghim H; Moradi M; Tajik N; Shahsavar F; Asadifar B
Iran J Immunol; 2010 Jun; 7(2):88-95. PubMed ID: 20574122
[TBL] [Abstract][Full Text] [Related]
9. Large spectrum of HLA-C recognition by killer Ig-like receptor (KIR)2DL2 and KIR2DL3 and restricted C1 SPECIFICITY of KIR2DS2: dominant impact of KIR2DL2/KIR2DS2 on KIR2D NK cell repertoire formation.
David G; Djaoud Z; Willem C; Legrand N; Rettman P; Gagne K; Cesbron A; Retière C
J Immunol; 2013 Nov; 191(9):4778-88. PubMed ID: 24078689
[TBL] [Abstract][Full Text] [Related]
10. Killer immunoglobulin-like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemia.
Middleton D; Diler AS; Meenagh A; Sleator C; Gourraud PA
Tissue Antigens; 2009 Jun; 73(6):553-60. PubMed ID: 19493232
[TBL] [Abstract][Full Text] [Related]
11. Different KIRs confer susceptibility and protection to adults with latent autoimmune diabetes in Latvian and Asian Indian populations.
Shastry A; Sedimbi SK; Rajalingam R; Rumba I; Kanungo A; Sanjeevi CB
Ann N Y Acad Sci; 2008 Dec; 1150():133-8. PubMed ID: 19120281
[TBL] [Abstract][Full Text] [Related]
12. KIR2DS3 is associated with protection against acute myeloid leukemia.
Shahsavar F; Tajik N; Entezami KZ; Fallah Radjabzadeh M; Asadifar B; Alimoghaddam K; Ostadali Dahaghi M; Jalali A; Ghashghaie A; Ghavamzadeh A
Iran J Immunol; 2010 Mar; 7(1):8-17. PubMed ID: 20371915
[TBL] [Abstract][Full Text] [Related]
13. KIR2DL3 and the KIR ligand groups HLA-A-Bw4 and HLA-C2 predict the outcome of hepatitis B virus infection.
Di Bona D; Aiello A; Colomba C; Bilancia M; Accardi G; Rubino R; Giannitrapani L; Tuttolomondo A; Cascio A; Caiaffa MF; Rizzo S; Di Lorenzo G; Candore G; Duro G; Macchia L; Montalto G; Caruso C;
J Viral Hepat; 2017 Sep; 24(9):768-775. PubMed ID: 28211154
[TBL] [Abstract][Full Text] [Related]
14. [Relationship between expression of inhibitory killer cell immunoglobulin-like receptor HLA-Cw ligand and susceptibility to inflammatory bowel disease].
Zhang HX; Li JC; Liu ZJ
Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(44):3108-11. PubMed ID: 19159590
[TBL] [Abstract][Full Text] [Related]
15. Natural killer cell receptor variants and chronic hepatitis B virus infection in the Vietnamese population.
Auer ED; Tong HV; Amorim LM; Malheiros D; Hoan NX; Issler HC; Petzl-Erler ML; Beltrame MH; Boldt ABW; Toan NL; Song LH; Velavan TP; Augusto DG
Int J Infect Dis; 2020 Jul; 96():541-547. PubMed ID: 32422377
[TBL] [Abstract][Full Text] [Related]
16. Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis.
Lorentzen AR; Karlsen TH; Olsson M; Smestad C; Mero IL; Woldseth B; Sun JY; Senitzer D; Celius EG; Thorsby E; Spurkland A; Lie BA; Harbo HF
Ann Neurol; 2009 Jun; 65(6):658-66. PubMed ID: 19630074
[TBL] [Abstract][Full Text] [Related]
17. Influence of HLA-C environment on the spontaneous clearance of hepatitis C in European HIV-HCV co-infected individuals.
Legrand N; David G; Rodallec A; Gaultier A; Salmon D; Cesbron A; Wittkop L; Raffi F; Gendzekhadze K; Retière C; Allavena C; Gagne K
Clin Exp Immunol; 2021 Apr; 204(1):107-124. PubMed ID: 33314121
[TBL] [Abstract][Full Text] [Related]
18. Increased frequencies of the killer immunoglobulin-like receptor genes KIR2DL2 and KIR2DS2 are associated with neuroblastoma.
Keating SE; Ní Chorcora C; Dring MM; Stallings RL; O'Meara A; Gardiner CM
Tissue Antigens; 2015 Sep; 86(3):172-7. PubMed ID: 26202659
[TBL] [Abstract][Full Text] [Related]
19. Killer cell immunoglobulin-like receptors and response to antiviral treatment in Thai patients with chronic hepatitis C virus genotype 3a.
Vejbaesya S; Nonnoi Y; Tanwandee T; Srinak D
J Med Virol; 2011 Oct; 83(10):1733-7. PubMed ID: 21755501
[TBL] [Abstract][Full Text] [Related]
20. Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay.
Tajik N; Shahsavar F; Nasiri M; Radjabzadeh MF
Int J Immunogenet; 2010 Jun; 37(3):159-68. PubMed ID: 20193031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]